Prosecution Insights
Prosecution Insights
Technology area: Biotechnology & Pharmaceuticals
2 pending office actions • 1 art units • 2 examiners • 0 of 2 (0%) have an AI response strategy ready • 8 patents granted in the last 365 days
Hm Clause Inc. is currently navigating 2 pending office actions within the Biotechnology & Pharmaceuticals technology area. These actions are concentrated within 1 distinct art unit, suggesting a narrow technical focus for the company's current patent applications. Despite the art unit, the prosecution involves 2 distinct examiners, which requires the company to manage different examiner styles and preferences simultaneously. CHRISTINA L MEADOWS is the busiest examiner for the portfolio, currently handling 1 pending office action.
This means that the workload is split, as each of the distinct examiners is responsible for a pending action. For practitioners, this distribution within the art unit highlights a need for consistency in arguments across different examiners. The presence of the 2 pending office actions in the Biotechnology & Pharmaceuticals sector reflects the ongoing intellectual property activity for Hm Clause Inc. in this specific field. Dealing with different examiners like CHRISTINA L MEADOWS within the 1 distinct art unit requires careful attention to how each individual interprets the technical disclosures. The pending office actions represent the current hurdles to patent grant in this specialized area. Successfully managing the distinct examiners is key to advancing the portfolio within the art unit.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §112 only | 2 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| MEADOWS, CHRISTINA L | 1 | 76.1% | +23.2% |
| BUI, PHUONG T | 1 | 81.2% | +23.2% |
Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18498670 | TETRAPLOID WATERMELON LINE NAMED W087YR | BUI, PHUONG T | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18799465 | HYBRID TOMATILLO PLANT NAMED BOTERO | MEADOWS, CHRISTINA L | 2d overdue |
| 18498670 | TETRAPLOID WATERMELON LINE NAMED W087YR | BUI, PHUONG T | — |
| Art Unit | Apps |
|---|---|
| 1663 | 2 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18799465 | HYBRID TOMATILLO PLANT NAMED BOTERO | MEADOWS, CHRISTINA L | 1663 | §112 | Final Rejection | 2d overdue | Pending | Aug 09, 2024 |
| 18498670 | TETRAPLOID WATERMELON LINE NAMED W087YR | BUI, PHUONG T | 1663 | §112 | Non-Final OA | — | Pending | Oct 31, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial